CGEM
Price
$7.40
Change
-$0.09 (-1.20%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
438.85M
46 days until earnings call
DNLI
Price
$11.77
Change
-$1.02 (-7.97%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
1.71B
39 days until earnings call
Ad is loading...

CGEM vs DNLI

Header iconCGEM vs DNLI Comparison
Open Charts CGEM vs DNLIBanner chart's image
Cullinan Therapeutics
Price$7.40
Change-$0.09 (-1.20%)
Volume$59.15K
Capitalization438.85M
Denali Therapeutics
Price$11.77
Change-$1.02 (-7.97%)
Volume$17.66K
Capitalization1.71B
CGEM vs DNLI Comparison Chart
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. DNLI commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and DNLI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (CGEM: $7.49 vs. DNLI: $12.79)
Brand notoriety: CGEM and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 131% vs. DNLI: 123%
Market capitalization -- CGEM: $438.85M vs. DNLI: $1.71B
CGEM [@Biotechnology] is valued at $438.85M. DNLI’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 5 bullish TA indicator(s).

  • CGEM’s TA Score: 4 bullish, 4 bearish.
  • DNLI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than CGEM.

Price Growth

CGEM (@Biotechnology) experienced а -9.65% price change this week, while DNLI (@Biotechnology) price change was -9.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

CGEM is expected to report earnings on May 20, 2025.

DNLI is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($1.71B) has a higher market cap than CGEM($439M). DNLI (-37.242) and CGEM (-38.506) have similar YTD gains . CGEM has higher annual earnings (EBITDA): -196.61M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. CGEM (399M). CGEM has less debt than DNLI: CGEM (2.15M) vs DNLI (48.7M). CGEM (0) and DNLI (0) have equivalent revenues.
CGEMDNLICGEM / DNLI
Capitalization439M1.71B26%
EBITDA-196.61M-492.89M40%
Gain YTD-38.506-37.242103%
P/E RatioN/AN/A-
Revenue00-
Total Cash399M832M48%
Total Debt2.15M48.7M4%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMDNLI
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 24 days ago
72%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALPCX10.54N/A
N/A
American Century Focused Lg Cap Val C
GSQRX30.81N/A
N/A
Goldman Sachs Small Cap Value R
MACEX12.86N/A
N/A
Martin Currie Emerging Markets A
TRHZX149.08N/A
N/A
T. Rowe Price Equity Index 500 Z
MIIOX25.32N/A
N/A
Marsico International Opportunities Inst

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-4.22%
MDGL - CGEM
50%
Loosely correlated
-2.24%
GOSS - CGEM
45%
Loosely correlated
-3.79%
ORMP - CGEM
42%
Loosely correlated
-1.82%
IDYA - CGEM
38%
Loosely correlated
-4.77%
DNLI - CGEM
38%
Loosely correlated
-6.91%
More